To test whether there is a difference in the expression of interleukin 8 (IL8) between Crohn's disease and ulcerative colitis and to determine the main site of its synthesis this study analysed IL8 in mucosal biopsy specimens ofpatients with Crohn's disease and ulcerative colitis by enzyme linked immunosorbent assay (ELISA) and by in situ hybridisation. IL8 was measured by ELISA in 38 normal control patients, eight inflammatory control patients, 55 Crohn's disease biopsy specimens (26 patients), and 67 ulcerative colitis biopsy specimens (35 patients). IL8 mRNA was determined in samples by in situ hybridisation using a specific IL8 RNA probe. IL8 protein was significantly increased in macroscopically inflamed specimens of Crohn's disease (median 118 pg/specimen, p<0.0001), ulcerative colitis (median 140 pg/specimen, p<0001), and inflammatory controls (median 30 pg/specimen, p=0.010) compared with normal controls (median 4 pg/specimen). IL8 was also increased in uninflamed specimens of Crohn's disease (median 46 pg/specimen, p<0 001) but not of ulcerative colitis patients (median 9 pg/specimen, p=0.3). IL8 protein in the mucosa correlated significantly with macroscopic inflammation in Crohn's disease (r=0.47, p<0001) and in ulcerative colitis (r=0.60, p<0 001). IL8 mRNA was detected by in situ hybridisation in 31 of 55 biopsy specimens (56%) ofCrohn's disease patients, in 38 of 67 specimens of ulcerative colitis patients (57%), in five of eight inflammatory controls (63%) and in five of 38 normal controls (130/o). Mucosal IL8 mRNA expression correlated with mucosal IL8 protein (r=0.46, p<0.001). IL8 mRNA was only detected in inflammatory cells of the interstitium but not in mucosal epithelial cells. IL8 is produced mainly in the lamina propria of the colon in inflammatory bowel disease and correlates with mucosal inflammation. (Gut 1996; 38: 216-222) 
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(Gut 1996; 38: 216-222) Keywords follows: 0 (n= 17), 1 (n= 13), 2 (n=7), 3 (n=20). Specimens for histological assessments (0=normal, 1 =low degree of inflammation, 2=moderate inflammation, 3=severe inflammation), for the determination of IL8 protein by ELISA and for the determination of IL8 mRNA by in situ hybridisation were taken from essentially the same regions. Histological assessment of the degree of inflammation correlated well with the macroscopic assessment in Crohn's disease (r=0-66, p<0-001) and in ulcerative colitis (r=0-70, p<0-001).
The mean (SD) weight of samples was 7.9 (2.3) mg with no difference between samples taken from control patients (8-1 (2.2) mg), Crohn's disease patients (7-6 (2A4) mg) or ulcerative colitis patients (8.1 (2-1) mg). Specimens for IL8 protein determination were washed in phosphate buffered saline (PBS) and then immediately frozen at -20°C. Biopsy specimens for IL8 mRNA detection were taken up in freshly prepared 4% paraformaldehyde. After prefixation overnight they were taken up in OCT-compound (Tissue-Tek Miles, Elkhart, IN, USA) and frozen at -20°C. Figure 3 : Semiquantitative determination ofIL8 mRNA expression in colonic mucosa by in situ hybridisation. IL8 mRNA was localised by in situ hybridisation using 35S-UTP labelled IL8 antisense RNA as described in methods. Thirty eight normal control specimens (n Co), eight inflammatory control specimens (i Co), 55 Crohn's disease specimens (CD), and 67 ulcerative colitis specimens (UC) were analysed. Inflammation was assessed macroscopically (0=normal mucosa, 1 =low degree of inflammation, 2=moderate inflammation, 3=severe inflammation). The figure shows the percentage of specimens in each group expressing IL8. p=0001). Figure 1 shows the individual data.
When mucosal IL8 concentrations were compared intraindividually between sites with different degrees of inflammation (Fig 2) In situ hybridisation Cells expressing IL8 could be detected by in situ hybridisation using a specific 35S-UTP labelled IL8 antisense RNA probe in five of 38 normal controls (13%) and five of eight inflammatory controls (63%), in 31 of 55 specimens of Crohn's disease patients (56%), and in 38 of 67 specimens of ulcerative colitis patients (57%/o) (Fig 3) . When IL8 mRNA expression was determined semiquantitatively the IL8 mRNA expression in normal biopsy specimens was mainly low (50/o) or moderate (80/o). Also IL8 expression in inflammatory controls was mainly low (63%). In Crohn's disease, however, 32% showed a low, 20% a moderate, and 4%/o a strong expression of IL8 mRNA. The corresponding values in ulcerative colitis specimens were 29% for low expression, 12% for moderate expression, and 16% for strong expression.
When mucosal IL8 mRNA expression was correlated with mucosal IL8 protein concentrations a statistically significant correlation was found (r=0-46, p<0 001) (Fig 4) . There was also a statistically significant correlation between the macroscopic score of inflammation and the amount of IL8 mRNA detected by in situ hybridisation (r=0.51, p<0001).
The analysis of the cell types expressing IL8 mRNA showed that in none of the 168 specimens IL8 mRNA was expressed in detectable amounts in mucosal epithelial cells. Cells positive for IL8 mRNA were always located in the mucosa, presumably representing infiltrating inflammatory cells. Figure 5 shows examples for the detection of IL8 mRNA in a normal control patient as well as in a patient with Crohn's disease with strong expression of IL8 mRNA, and in a patient with ulcerative colitis, also showing strong expression of IL8 mRNA. In the case of the two inflammatory bowel disease patients IL8 sense RNA probes were used as specificity controls.
IL8 mRNA expression It has previously been described that IL8 is mainly increased in active ulcerative colitis but not in Crohn's disease.'3 The different regulation of IL8 in Crohn's disease and in ulcerative colitis would have been of great pathophysiological interest, as both diseases show some differences in their histopathological appearance. While infiltration with neutrophils and the formation of crypt abscesses is a hallmark of ulcerative colitis, Crohn's disease is characterised by granulomas. 28 29 In the case of IL6 it has been shown that there is a difference between Crohn's disease and ulcerative colitis.24 25 Its circulatory concentrations were more increased in patients with Crohn's disease than in patients with ulcerative colitis suggesting that there is a persisting stimulation of IL6 producing 1L8 in IBD 221 cells in Crohn's disease but not in ulcerative colitis. 25 We found that IL8 concentrations in the inflamed mucosa are similar for Crohn's disease and ulcerative colitis. IL8 expression is increased independent of the cause of the inflammation including also the inflammatory controls. The apparent discrepancy between our findings and those of Mahida'3 
